Odesivimab
Modify Date: 2024-04-06 10:10:09
Odesivimab structure
|
Common Name | Odesivimab | ||
|---|---|---|---|---|
| CAS Number | 2135632-30-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OdesivimabOdesivimab is a humanized monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1]. |
| Name | Odesivimab |
|---|
| Description | Odesivimab is a humanized monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Odesivimab (REGN-3471) 在体外中和假病毒颗粒。Odesivimab 与 Atoltivimab 和 Maftivimab 的 IC50 值为 0.39 nM[1]。 |
| In Vivo | Odesivimab 与 Atoltivimab 和Maftivimab (REGN-3471; 50 mg/kg) 对埃博拉病毒感染的恒河猴模型具有保护作用[1]。 |
| References |
[1]. Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81(1):175-178. |
| No Any Chemical & Physical Properties |